Trase (trase.ai), a Virginia-based agentic AI platform for regulated industries, has raised $107M in seed funding led by ARCH Venture Partners. The company provides an operating system, SDK, and pre-built agent marketplace that enables production deployment of autonomous agents in under 30 days with built-in compliance, data sovereignty, and auditability. The capital will support expansion across healthcare and government verticals.
Record Seed Underscores Governance Gap
The timing aligns with a surge in agentic AI investment. Hippocratic AI raised $404M including a $126M Series C in November 2025, while Autonomize AI secured $32M in a June 2025 Series A. Kore.ai raised $422M total with strategic funding from FTV Capital and Nvidia in January 2024. Trase differentiates by embedding governance into the core OS rather than layering it on later, targeting environments where data cannot leave customer infrastructure.
Security Reviews Stall Most Deployments
Only 11% of agentic AI deployments reach production, primarily due to governance, security, and reliability barriers. Regulated sectors face acute friction from requirements like HIPAA, FedRAMP, and ITAR. Current solutions often require moving data to cloud platforms, creating compliance conflicts for defense and healthcare customers.
OS Built for Sovereign Deployment
Trase Origin delivers the infrastructure layer that orchestrates agents across cloud, on-prem, and air-gapped setups while enforcing immutable audit trails and human escalation paths. Trase Leagues offers over 50 pre-built agents for workflows such as prior authorization, claims scrubbing, and nurse rostering. This contrasts with competitors focused on narrower verticals or conversational interfaces without native support for classified environments.
As CEO Grant Verstandig noted in the company blog:
"The fax problem sounds small. In the full scope of American healthcare, it is. But it's where trust gets built."
Duke Health's cardiology division automated 1,400 monthly hours of fax processing with 98.1% accuracy, returning 1,395 hours per month to staff.
ARCH Backs Institutional AI Infrastructure
ARCH Venture Partners led the round with participation from Red Cell Partners. The investor profile signals conviction in mission-critical sectors where AI must meet defense-grade security standards. Trase's leadership includes President Baskar Sridharan, former VP and GM of AWS Bedrock and SageMaker, and CTO Srirama Koneru, former GM of AWS Bedrock.
Agentic Market Expands Rapidly
The global AI agents market stands at $10.9B in 2026 estimates and is projected to reach $182.9B by 2033 at a 49.6% CAGR. Enterprise spending on agentic AI is forecasted at $201.9B in 2026. Trase competes with UiPath's RPA-derived automation and SimplAI's $2.5M bootstrapped OS, but stands apart through its defense authorizations and pay-for-success pricing model.
Leadership Drawn from Cloud AI Giants
The founding and early team includes Red Cell Partners founder Grant Verstandig as CEO and advisors such as former U.S. Secretary of Defense Mark T. Esper. This concentration of domain expertise from AWS Bedrock and national security distinguishes the company in a market where most platforms lack regulated-industry depth.
Series A and Acquisitions Planned
Trase intends to pursue a Series A exceeding $125M later this year alongside strategic tuck-in acquisitions to accelerate growth.